Although showing the resemblance between the expression pattern of Spry2 and that of several potential tumor markers in hepatocellular carcinoma, the investigators ruled out loss of heterozygosity (LOH) or the promoter hypermethylation as possible mechanisms responsible for Spry2 downregulation. This evidence concerns the gene SPRY2 and hepatocellular carcinoma.